You are here: Home ยป Archives for healthcare

KFSH&RC Pushes Boundaries with a Year of Achievements Across Three Centres of Excellence

RIYADH, Saudi Arabia, May 10, 2024 (GLOBE NEWSWIRE) — King Faisal Specialist Hospital & Research Centre (KFSH&RC) has experienced a year of achievements across its three Centres of Excellence—Oncology, Genomics, and Transplantation.

KFSH&RC’s Oncology Centre of Excellence continues to lead the fight against the disease in the Kingdom. This year alone, the centre has treated 25% of all cancer cases in Saudi Arabia, achieving a 50% overall recovery rate and up to 90% recovery in leukemia cases. With almost five decades of service, the centre’s commitment to providing advanced cancer treatments is evident in its adoption of technologies such as CAR T–cell therapy and liquid biopsy, which provide less invasive alternatives to traditional methods, along with extensive bone marrow transplants, and revolutionary techniques like Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Notably, KFSH&RC has achieved a milestone by completing over 100 CAR T–cell therapy procedures, a novel treatment that genetically modifies a patient's immune cells to fight cancer. This achievement puts it on par with renowned institutions that are also advancing CAR–T cell therapy for various blood cancers and exploring expanded applications through clinical trials and new treatment protocols. Furthermore, the centre’s focus on pediatric oncology boasts a 97% five–year survival rate for renal tumors and a 92% survival rate for acute lymphoblastic leukemia in children.

With rapid advancements in genomic medicine, KFSH&RC is adopting next–generation sequencing technologies into patient care in its Genomic Centre, revolutionizing local and regional approaches to disease management. KFSH&RC’s discovery of the bacterial strain Stenotrophomonas Riyadhensis, facilitated by whole–genome sequencing (WGS) technology, has contributed to our understanding of bacterial antibiotic resistance mechanisms. With 15,698 patient visits and over 5,658 whole genomes completed in 2023, the centre ensures that prevention, diagnosis, and treatment are precise and personalized.

KFSH&RC's Organ Transplant Centre of Excellence (OTCoE) continues to be the primary contributor to organ transplantation activities in the Kingdom, accounting for 65% of all transplants performed nationally. In 2023, OTCoE performed 1,092 solid organ transplants, including the world’s first fully robotic liver transplant— where doctors employed robotic technology to conduct surgery on both patient and donor — an achievement that places the centre at the forefront of global transplantation practices.

As KFSH&RC continues to push the boundaries of what is possible in medical science, its efforts not only inspire but also significantly impact the global healthcare community, reaffirming its role as a leader in medical innovation and specialized healthcare.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally for the second consecutive year. Additionally, in 2024, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non–profit, government–owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

CONTACT INFORMATION

For more information, please contact:

Mr. Essam Al–Zahrani, Acting Media Affairs Head, 0555254429

Mr. Abdullah Al–Aown, Media Coordination Officer, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/e99afd2f–d5c6–400e–9290–26b36a580bee


GLOBENEWSWIRE (Distribution ID 9115490)

King Faisal Specialist Hospital & Research Centre Leading Health Sector Transformation in Saudi Arabia

RIYADH, Saudi Arabia, May 09, 2024 (GLOBE NEWSWIRE) — Harvard University — Eight years into Vision 2030, Saudi Arabia has made significant strides with digital innovations and enhanced access to quality care. Strategic investments in infrastructure, technology, and talent, have led to advancements revolutionizing patient care delivery and elevating the standards of healthcare locally. These efforts have notably raised the average life expectancy, reduced mortality rates, and enhanced overall well–being across the Kingdom.

Central to these achievements, King Faisal Specialist Hospital & Research Centre (KFSH&RC), renowned for its specialized care and treatments across critical fields such as oncology, cardiology, organ transplantation, and genetics has positioned itself as a leader in specialized patient care, taking the charge towards a brighter, healthier future for the Kingdom. Through its commitment to pioneering digital health initiatives, comprehensive educational programs, and novel research endeavors, it is reshaping the local landscape, and setting new standards of efficiency and accessibility.

In an era defined by technological advancements, and with the Kingdom’s push towards digitalization, KFSH&RC stands at the forefront of digital health integration among its local peers, leveraging cutting–edge telemedicine services, virtual consultations, and AI–driven tools such as the ANFAL AI System that transforms patient outcomes through predictive insights and personalized care, ensuring the best outcomes for patient satisfaction.

KFSH&RC’s digital health initiatives extend to addressing broader health threats through technologies such as Whole Genomic Sequencing (WGS) and Advanced Radiation Therapy. The hospital has also pioneered organ transplantation by performing the world's first fully robotic liver transplant and introduced to the region innovations like the Harmony Transcatheter Pulmonary Valve (TPV), enhancing patient recovery and experience. These technologies facilitate personalized treatment plans and improve the accuracy and speed of medical diagnostics, contributing significantly to the elevation of patient care standards and a sustainable, resilient healthcare infrastructure in line with the objectives of the Health Sector Transformation Program.

KFSH&RC continues to push the boundaries of medical research addressing pressing health challenges and contributing to Saudi Arabia’s public health landscape, with discoveries like the PfAP2–MRP gene crucial for malaria treatment and the identification of the new Riyadhensis bacteria strain. These discoveries have not only improved diagnostic accuracy but also facilitated early interventions, ensuring timely and effective patient support, in line with the national objectives to reduce chronic disease prevalence.

These comprehensive efforts are supported by KFSH&RC’s robust educational initiatives, which prepare the next generation of medical professionals through training programs and international collaborations.

Recognized by ‘Brand Finance’ in 2024 as the most valuable healthcare brand in Saudi Arabia and the Middle East for the second consecutive year, placing 9th in Saudi Arabia and 28th in the Middle East. Additionally, KFSH&RC stands out as the only hospital worldwide to be ranked among its country's top ten most valuable brands.

About King Faisal Specialist Hospital & Research Centre (KFSH&RC):

King Faisal Specialist Hospital & Research Centre (KFSH&RC) stands as a leading healthcare institution in the Middle East, envisioned to be the optimal choice for every patient seeking specialized healthcare. The hospital boasts a rich history in the treatment of cancers, cardiovascular diseases, organ transplantation, neurosciences, and genetics.

In 2024, “Brand Finance” ranked King Faisal Specialist Hospital & Research Centre as the top academic medical centre in the Middle East and Africa, and among the top 20 globally for the second consecutive year. Additionally, in 2024, it was recognized as one of the leading global healthcare providers by Newsweek magazine.

As part of Saudi Vision 2030, a royal decree was issued on December 21, 2021, to transform the hospital into an independent, non–profit, government–owned entity, paving the way for a comprehensive transformation program aimed at achieving global leadership in healthcare through excellence and innovation.

CONTACT INFORMATION

For more information, please contact:

Mr. Essam Al–Zahrani, Media Affairs Head, 0555254429

Mr. Abdullah Al–Aown, Media Coordination Officer, 0556294232

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/003e76ab–3d93–42d4–9edf–5e652a14c559


GLOBENEWSWIRE (Distribution ID 9114722)

Le KFSH&RC se classe comme marque de soins de santé la plus valorisée en Arabie Saoudite et au Moyen-Orient

RIYAD, Arabie Saoudite, 03 mai 2024 (GLOBE NEWSWIRE) — Le KFSH&RC (King Faisal Specialist Hospital and Research Centre) se classe en tête du secteur de la santé en Arabie Saoudite et au Moyen–Orient, et se distingue pour la deuxième année comme la marque de soins de santé la plus valorisée dans ces régions. Selon les rapports de Brand Finance pour 2024, la marque s’est classée 9e en Arabie Saoudite et 28e au Moyen–Orient. De plus, le KFSH&RC se distingue comme unique hôpital au monde à figurer parmi les dix marques les plus valorisées dans le pays.

Le rapport de Brand Finance révèle que la valeur de marque du KFSH&RC a augmenté de 31 %, dépassant 5,6 milliards de riyals saoudiens, soit l’équivalent de 1,5 milliard de dollars. Cette augmentation est le résultat de l’engagement inébranlable de l’hôpital qui cherche à intégrer les derniers traitements médicaux et technologies, et à fournir des soins médicaux spécialisés conformes aux normes internationales les plus récentes.

M. Muhannad Kadi, directeur des communications et du marketing d’entreprise, revient pour nous sur cette reconnaissance mondiale dont bénéficie le KFSH&RC : « Ce succès illustre parfaitement l’engagement de l’hôpital pour atteindre les normes de qualité les plus élevées et offrir des soins d’exception, et reflète également la valeur importante qu’il offre à ses bénéficiaires. » Il souligne que la position de l’hôpital parmi les dix marques les plus valorisées d’Arabie Saoudite met en évidence non seulement sa rentabilité, mais également l’impact positif des changements en cours dans le secteur de la santé du pays.

Au cours de l’année écoulée, le KFSH&RC a franchi plusieurs étapes importantes qui ont contribué de manière significative à améliorer la solidité et la réputation de son image de marque. Cela inclut notamment la réalisation de quatre expériences révolutionnaires dans le domaine de la médecine spatiale, la réalisation de la première transplantation hépatique entièrement robotisée au monde et le lancement d’un service d’analyse rapide des données de séquençage du génome complet, accessible à tous les bénéficiaires. En outre, le KFSH&RC a célébré le traitement réussi de 100 patients atteints de leucémie lymphoblastique aiguë, preuve de nos capacités médicales avancées et de notre engagement dans les soins aux patients.

Dans la lignée du plan Saudi Vision 2030 et de ses programmes de transformation initiés par Son Altesse Royale, le Prince héritier et le Premier ministre, qui visent à renforcer la position du Royaume sur le plan international et à en faire un centre en matière de soins de santé, le KFSH&RC a été classé comme le meilleur centre médical universitaire au Moyen–Orient et en Afrique. Il s’est également hissé à la 20e place du classement des 250 meilleurs hôpitaux au monde par Brand Finance pendant deux années consécutives, en 2023 puis en 2024. Il figure également dans le classement des 250 meilleurs hôpitaux au monde publié par le magazine Newsweek.


GLOBENEWSWIRE (Distribution ID 9110946)

KFSH&RC ist die wertvollste Marke im Gesundheitswesen in Saudi-Arabien und im Nahen Osten

RIAD, Saudi–Arabien, May 03, 2024 (GLOBE NEWSWIRE) — KFSH&RC führt den Gesundheitssektor im Königreich Saudi–Arabien und im Nahen Osten an und ist zum zweiten Mal als wertvollste Gesundheitsmarke in diesen Regionen ausgezeichnet worden. Laut den Berichten von Brand Finance 2024 belegte das Krankenhaus in Saudi–Arabien Platz 9 und im Nahen Osten Platz 28. Darüber hinaus ist das KFSH&RC das einzige Krankenhaus weltweit, das zu den zehn wertvollsten Marken seines Landes zählt.

Aus dem Brand Finance Report geht hervor, dass der Markenwert des KFSH&RC um 31 % gestiegen ist und 5,6 Mrd. saudische Riyals, umgerechnet 1,5 Mrd. USD, überschritten hat. Dieser Anstieg ist das Ergebnis des unermüdlichen Engagements des Krankenhauses, die neuesten medizinischen Technologien und Behandlungen zu integrieren und eine spezialisierte medizinische Versorgung anzubieten, die den neuesten internationalen Standards entspricht.

Muhannad Kadi, Chief Corporate Communications & Marketing Officer, kommentierte die weltweite Anerkennung des KFSH&RC wie folgt: „Diese Leistung unterstreicht das Engagement des Krankenhauses, höchste Qualitätsstandards zu erreichen und eine hervorragende Gesundheitsversorgung zu bieten, sowie den bedeutenden Wert, den es seinen Nutznießern bietet.“ Er betonte, dass die Position des Krankenhauses unter den zehn wertvollsten Marken in Saudi–Arabien nicht nur seine Effektivität unterstreicht, sondern auch die positiven Auswirkungen des laufenden Wandels im Gesundheitssektor des Königreichs.

Im vergangenen Jahr hat das KFSH&RC mehrere bemerkenswerte Meilensteine erreicht, die wesentlich zur Stärke und zum Ansehen der Marke beigetragen haben. Dazu gehören die Durchführung von vier bahnbrechenden Experimenten in der Weltraummedizin, die erste vollständig robotergestützte Lebertransplantation der Welt und die Einführung eines Schnellanalysedienstes für die Sequenzierung des gesamten Genoms, der allen Begünstigten zur Verfügung steht. Darüber hinaus konnte das KFSH&RC die erfolgreiche Behandlung von 100 Patienten mit T–Zell–Lymphoblasten–Leukämie feiern – ein Beweis für unsere fortschrittlichen medizinischen Fähigkeiten und unser Engagement für die Patientenversorgung.

Im Einklang mit der saudischen Vision 2030 und den von Seiner Königlichen Hoheit, dem Kronprinzen und Premierminister, initiierten Transformationsprogrammen, die darauf abzielen, die globale Position des Königreichs zu stärken und es als Drehscheibe des Gesundheitswesens zu etablieren, wurde das KFSH&RC als das beste akademische medizinische Zentrum im Nahen Osten und Afrika eingestuft. Es sicherte sich auch den 20. Platz weltweit für zwei aufeinanderfolgende Jahre, 2023 und 2024, laut dem Global Top 250 Hospitals Report von Brand Finance. Außerdem wurde es vom Newsweek Magazine unter die 250 besten Krankenhäuser der Welt gewählt.


GLOBENEWSWIRE (Distribution ID 9110946)

KFSH&RC Classificado como a Melhor Marca de Cuidados de Saúde da Arábia Saudita e Oriente Médio

RIADE, Arábia Saudita, May 03, 2024 (GLOBE NEWSWIRE) — O KFSH&RC lidera o setor de saúde do Reino da Arábia Saudita e do Oriente Médio, reconhecido como a marca de saúde mais valiosa nessas regiões pelo segundo ano. De acordo com os relatórios do Brand Finance de 2024, ficou em 9o lugar na Arábia Saudita e em 28o no Oriente Médio. Além disso, o KFSH&RC se destaca como o único hospital do mundo a ser classificado entre as dez marcas mais valiosas do país.

O Brand Finance Report mostra que o valor da marca KFSH&RC aumentou 31%, excedendo 5,6 bilhões de riais sauditas, o equivalente a US$ 1,5 bilhão. Esse aumento é o resultado do compromisso inabalável do hospital em incorporar as mais recentes tecnologias e tratamentos médicos e fornecer atendimento médico especializado que atenda aos mais recentes padrões internacionais.

Refletindo sobre o reconhecimento global do KFSH&RC, o Sr. Muhannad Kadi, Diretor de Comunicações Corporativas e Marketing, comentou: “Esta conquista ressalta a dedicação do hospital em alcançar os mais altos padrões de qualidade e fornecer cuidados de saúde excelentes, bem como o valor significativo que oferece aos seus beneficiários.” Ele enfatizou que a posição do hospital entre as dez marcas mais valiosas da Arábia Saudita não apenas ressalta sua eficácia, mas também o impacto positivo das transformações em andamento do setor de saúde do Reino.

No ano passado, o KFSH&RC alcançou vários marcos notáveis que contribuíram significativamente para a força e reputação da sua marca. Isso inclui a realização de quatro experimentos inovadores em medicina espacial, a realização do primeiro transplante de fígado totalmente robótico do mundo e o lançamento de um serviço rápido de análise de sequenciamento de genoma completo disponível para todos os beneficiários. Além disso, o KFSH&RC celebrou o tratamento bem–sucedido de 100 pacientes com leucemia linfoblástica de células T, um testemunho da nossa capacidade médica avançada e dedicação ao atendimento do paciente.

De acordo com a Saudi Vision 2030 e seus programas de transformação, iniciados por Sua Alteza Real, o Príncipe Herdeiro e o Primeiro–Ministro – que visam melhorar a posição global do Reino e estabelecê–lo como um centro de saúde – o KFSH&RC foi classificado como o melhor Centro Médico Acadêmico do Oriente Médio e da África. Também garantiu o 20º lugar globalmente por dois anos consecutivos, 2023 e 2024, de acordo com o relatório Global Top 250 Hospitals da Brand Finance. Além disso, ele foi classificado entre os melhores hospitais do mundo do 250 Best Hospitals in the World da revista Newsweek.


GLOBENEWSWIRE (Distribution ID 9110946)

“التخصصي” العلامة التجارية الصحية الأعلى قيمة في السعودية والشرق الأوسط

RIYADH, Saudi Arabia, May 02, 2024 (GLOBE NEWSWIRE) —

تصدّر مستشفى الملك فيصل التخصصي ومركز الأبحاث القطاع الصحي بالمملكة العربية السعودية والشرق الأوسط، بتصنيفه العلامة التجارية الصحية الأعلى قيمة في المملكة والشرق الأوسط للسنة الثانية على التوالي، حيث حل بالمرتبة التاسعة في المملكة، والثامنة والعشرون في الشرق الأوسط، وتفرد “التخصصي“ بكونه المستشفى الوحيد عالمياً الذي يأتي ضمن أعلى 10 علامات تجارية قيمة في بلده، وذلك بحسب تقريرين لـ “براند فاينانس” حول العلامات التجارية الـ 50 الأعلى قيمة في السعودية، والعلامات التجارية الـ 150 الأعلى قيمة في الشرق الأوسط للعام 2024.

وأوضح التقرير ارتفاع قيمة العلامة التجارية للتخصصي بنسبة 31% لتتجاوز الـ 5.6 مليار ريال سعودي – ما يعادل 1.5 مليار دولار أمريكي–، حيث تُعد هذه الزيادة نتيجة لالتزام مستشفى الملك فيصل التخصصي ومركز الأبحاث بدمج أحدث التقنيات الطبية والعلاجات، وتوفير الرعاية الطبية التخصصية بأحدث المعايير العالمية على مدى ما يقارب خمسة عقود وتطويره لمجال الأبحاث ورعاية المرضى بشكل مستمر.

وقال الأستاذ مهند عبدالله قاضي، الرئيس التنفيذي للاتصال المؤسسي والتسويق في مستشفى الملك فيصل التخصصي ومركز الأبحاث، “إن هذا الإنجاز يأتي انعكاس لالتزام المستشفى بتحقيق أعلى معايير الجودة وتقديم رعاية صحية متميزة، وكذلك للقيمة التي يقدمها للمستفيدين”، موكداً أن التواجد ضمن أعلى 10 علامات تجارية قيمةً في المملكة شاهداً على نجاعة التحولات التي يعيشها القطاع الصحي في المملكة.

وحقق “التخصصي“ في العام الماضي عددا من الإنجازات يأتي في مقدمتها، تنفيذ أربع تجارب رائدة في مجال طب الفضاء، وإجراء أول زراعة كبد كاملة بالروبوت في العالم، وتدشين خدمة تحليل تسلسل الجينوم الكامل السريع وإتاحتها لجميع المستفيدين، كما احتفى “التخصصي” بنجاح علاج 100 مريض بسرطان الدم اللمفاوي باستخدام الخلايا التائية، ما انعكس إيجاباً على درجة مؤشر قوة العلامة التجارية، التي ارتفعت إلى 37.9من 100.

وتعدّ نتيجة التصنيف شاهدة على الكفاءة العالية والتميز الذي يتمتّع به الكادر الطبي والبحثي في “التخصصي”، وثمرة لبرامج التحول ورؤية السعودية 2030 التي أطلقها سمو ولي العهد رئيس مجلس الوزراء، حفظه الله، التي تهدف إلى تعزيز ريادة المملكة في قطاع الرعاية الصحية على المستوى العالمي، ما أثمر عن تصنيف مستشفى الملك فيصل التخصصي ومركز الأبحاث في مقدمة المؤسسات الصحية الأكاديمية في الشرق الأوسط وأفريقيا، والـ 20 عالميًا، لعامين متتاليين 2023 و2024 بحسب “براند فاينانس”، وكذلك تصنيفه ضمن قائمةَ أفضل 250 مستشفى على مستوى العالم لعام 2024 والصادرة عن مجلة “نيوزويك” الأمريكية.


GLOBENEWSWIRE (Distribution ID 9110177)

KFSH&RC Ranked Top Valuable Healthcare Brand in Saudi Arabia and Middle East

RIYADH, Saudi Arabia, May 02, 2024 (GLOBE NEWSWIRE) — KFSH&RC tops the healthcare sector in the Kingdom of Saudi Arabia and the Middle East, recognizing it as the most valuable healthcare brand in these regions for the second year. According to the 2024 Brand Finance reports, it placed 9th in Saudi Arabia and 28th in the Middle East. Additionally, KFSH&RC stands out as the only hospital worldwide to be ranked among its country's top ten most valuable brands.

The Brand Finance Report shows that KFSH&RC brand value increased by 31%, exceeding 5.6 billion Saudi Riyals, equivalent to USD 1.5 billion. This increase is the result of the hospital's unwavering commitment to incorporating the latest medical technologies and treatments and providing specialized medical care that adheres to the latest international standards.

Reflecting on KFSH&RC’s global recognition, Mr. Muhannad Kadi, the Chief Corporate Communications & Marketing Officer, commented, “This accomplishment underscores the hospital’s dedication to achieving the highest quality standards and providing outstanding healthcare, as well as the significant value it delivers to its beneficiaries.” He emphasized that the hospital’s position among the top ten most valuable brands in Saudi Arabia not only highlights its effectiveness but also the positive impact of the ongoing transformations within the Kingdom’s healthcare sector.

Over the past year, KFSH&RC has achieved several notable milestones that have significantly contributed to its brand strength and reputation. These include conducting four ground–breaking experiments in space medicine, performing the World's first fully robotic liver transplant, and launching a rapid whole genome sequencing analysis service available to all beneficiaries. Furthermore, KFSH&RC celebrated the successful treatment of 100 T–cell lymphoblastic leukemia patients, a testament to our advanced medical capabilities and dedication to patient care.

In line with Saudi Vision 2030 and its transformation programs, initiated by His Royal Highness, the Crown Prince and Prime Minister—which aim to enhance the Kingdom's global position and establish it as a healthcare hub—KFSH&RC has been ranked as the top Academic Medical Centre in the Middle East and Africa. It also secured the 20th spot globally for two consecutive years, 2023 and 2024, according to Brand Finance's Global Top 250 Hospitals report. Additionally, it has been ranked among the top 250 Best Hospitals in the World by Newsweek Magazine.

 


GLOBENEWSWIRE (Distribution ID 9110177)

KFSH&RC begrüßt Dr. Björn Zoéga als neuen stellvertretenden CEO

RIAD, Saudi–Arabien, April 03, 2024 (GLOBE NEWSWIRE) — Das King Faisal Specialist Hospital and Research Centre (KFSH&RC) freut sich, die Ernennung von Dr. Björn Zoéga zum stellvertretenden Chief Executive Officer (CEO) mit Wirkung vom 1. April 2024 bekanntzugeben. Mit dieser strategischen Ernennung möchte das KFSH&RC seinem Bestreben, eine weltweit führende Gesundheitseinrichtung zu werden, zusätzlichen Antrieb geben, indem es die bemerkenswerte Karriere von Dr. Zoéga und seine nachgewiesene Führungserfahrung in hochrangigen medizinischen Einrichtungen nutzt.

Als ehemaliger CEO des international renommierten Karolinska–Universitätskrankenhauses in Schweden spielte Dr. Zoéga eine entscheidende Rolle bei der Aufrechterhaltung der hohen Standards der Einrichtung und ihrer weltweiten Anerkennung als zweitbestes Krankenhaus in Europa und siebtbestes weltweit laut der von Newsweek herausgegebenen Rangliste der besten Krankenhäuser der Welt 2024. Seine Zeit im Karolinska–Krankenhaus war von innovativen Strategien und Spitzenleistungen in der Gesundheitsversorgung geprägt, die er im KFSH&RC weiter ausbauen möchte.

Dr. Zoéga bringt jahrzehntelange Erfahrung im Management des Gesundheitswesens und im klinischen Bereich in das KFSH&RC ein, nachdem er als CEO des Nationalen Universitätskrankenhauses von Island und des Stockholmer Wirbelsäulenzentrums an der Spitze der Einrichtungen stand. Sein Wissens– und Erfahrungsschatz in Forschung und Lehre, den er sich als früherer Präsident und Verwaltungsratsvorsitzender der EU–Gesellschaft für Halswirbelsäulenforschung und als Vorsitzender des wissenschaftlichen Beirats von Alvotech aneignen konnte, stellen eine zusätzliche Bereicherung dar.

In seiner Funktion als stellvertretender CEO wird Dr. Zoéga die Bereiche Gesundheitsversorgung sowie Forschung und Innovation des KFSH&RC leiten und damit das Engagement des Krankenhauses für die Integration weltweit bewährter Praktiken im Gesundheitswesen und die Förderung modernster medizinischer Forschung und Technologie fortsetzen.

Das KFSH&RC lädt die Gemeinschaft, Partner und Interessengruppen ein, Dr. Björn Zoéga willkommen zu heißen, und freut sich auf ein vielversprechendes neues Kapitel in der Gesundheitsversorgung, das eine bessere und gesündere Zukunft für alle fördern soll.

Für weitere Informationen kontaktieren Sie bitte:

Essam Al–Zahrani, Media Affairs Acting Head, 0555254429

Abdullah Al–Awn, Senior Media Editor, 0556294232

Ein Foto zu dieser Mitteilung ist verfügbar unter https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e


GLOBENEWSWIRE (Distribution ID 9084058)

Le KFSH&RC accueille le Dr Björn Zoëga en tant que nouveau directeur général adjoint

RIYAD, Arabie saoudite, 03 avr. 2024 (GLOBE NEWSWIRE) — Le King Faisal Specialist Hospital and Research Centre (KFSH&RC) est fier d’annoncer la nomination du Dr Björn Zoëga au poste de directeur général adjoint, à compter du 1er avril 2024. Cette décision stratégique vise à accélérer l’aspiration du KFSH&RC à devenir un établissement de soins de santé de premier plan sur la scène mondiale, en s’appuyant sur la carrière remarquable du Dr Zoëga et ses antécédents avérés en matière de leadership dans des établissements médicaux de premier plan.

En tant qu’ancien directeur général de l’hôpital universitaire Karolinska de Suède, de renommée internationale, le Dr Zoëga a joué un rôle essentiel dans le maintien des normes élevées de l’établissement et de sa reconnaissance mondiale en tant que deuxième hôpital le mieux classé parmi les hôpitaux européens et septième au niveau mondial selon le classement de Newsweek des meilleurs hôpitaux du monde en 2024. Son administration à Karolinska a été marquée par des stratégies innovantes et l’excellence en termes de prestations de santé, autant d’éléments qu’il se propose d’enrichir au sein du KFSH&RC.

Le Dr Zoëga apporte au KFSH&RC des décennies d’expérience en gestion des soins de santé et d’expertise clinique, après avoir dirigé les opérations en tant que directeur général de l’hôpital universitaire national d’Islande et du Stockholm Spine Center. Son expérience et ses compétences en matière de recherche et d’éducation sont également inestimables, compte tenu de ses anciens rôles de président et de président du conseil d’administration de l’EU–Cervical Spine Research Society et de président du Conseil consultatif scientifique d’Alvotech.

En tant que directeur général adjoint, le Dr Zoëga dirigera les groupes de prestation de soins de santé et de recherche et d’innovation du KFSH&RC, conformément à l’engagement de l’hôpital d’intégrer les meilleures pratiques mondiales en matière de soins de santé et de poursuivre la recherche médicale et la technologie de pointe.

Le KFSH&RC invite la communauté, les partenaires et les parties prenantes à accueillir le Dr Björn Zoëga, tandis que l’établissement entame un nouveau chapitre prometteur dans le domaine des soins de santé, en s’engageant à favoriser un avenir plus brillant et plus sain pour tous.

Pour plus d’informations, veuillez contacter :

M. Essam Al–Zahrani, chef par intérim des affaires médiatiques, 0555254429

M. Abdullah Al–Awn, rédacteur en chef des médias, 0556294232

Une photo accompagnant ce communiqué est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e


GLOBENEWSWIRE (Distribution ID 9084058)

KFSH&RC Dá Boas-Vindas ao Novo CEO Adjunto Dr. Björn Zoéga

RIADE, Arábia Saudita, April 03, 2024 (GLOBE NEWSWIRE) — O King Faisal Specialist Hospital and Research Centre (KFSH&RC) tem o orgulho de anunciar a nomeação do Novo CEO Adjunto Dr. Björn Zoéga em 1 de abril de 2024. Esse movimento estratégico deve acelerar o objetivo da KFSH&RC de se tornar uma instituição de saúde líder no cenário global, alavancando a notável carreira e o histórico comprovado de liderança do Dr. Zoéga em instituições médicas de primeira linha.

Como ex–CEO do internacionalmente renomado Karolinska University Hospital, na Suécia, o Dr. Zoéga desempenhou um papel fundamental na defesa dos altos padrões e do reconhecimento global da instituição como o segundo mais bem avaliado entre os hospitais europeus e o sétimo melhor do mundo, de acordo com o ranking da Newsweek dos Melhores Hospitais do Mundo 2024. Sua administração da Karolinska foi marcada por estratégias inovadoras e excelência na prestação de cuidados de saúde – tudo o que ele pretende aprimorar no KFSH&RC.

No KFSH&RC, o Dr. Zoéga irá utilizar suas décadas de gestão de saúde e experiência clínica, na liderança em operações como CEO do National University Hospital da Islândia e do Stockholm Spine Center. Sua experiência e competência em pesquisa e educação também são inestimáveis, como nas suas funções anteriores na qualidade de Presidente e Presidente do Conselho da Sociedade de Pesquisa da Coluna Cervical da UE e Presidente do Conselho Consultivo Científico da Alvotech.

Como CEO Adjunto, o Dr. Zoéga atuará como líder dos grupos de prestação de cuidados de saúde e pesquisa e inovação do KFSH&RC, seguindo o compromisso do hospital em integrar as melhores práticas globais em cuidados de saúde e buscar pesquisas e tecnologias médicas de ponta.

O KFSH&RC estende seu convite à comunidade, parceiros e partes interessadas a dar as boas–vindas ao Dr. Björn Zoéga, nesse novo capítulo promissor que a instituição embarca na área da saúde, comprometida em promover um futuro mais brilhante e saudável para todos.

Para mais informações, contate:

Sr. Essam Al–Zahrani, Dirigente Interino de Assuntos de Mídia, 0555254429

Sr. Abdullah Al–Awn, Editor Sênior de Mídia, 0556294232

Foto deste comunicado disponível em https://www.globenewswire.com/NewsRoom/AttachmentNg/6a2fb3b5–9219–4e72–82fd–8f093f22996e 


GLOBENEWSWIRE (Distribution ID 9084058)